Skip to main content
Allogene Therapeutics, Inc. (ALLO)
NASDAQ: ALLO · Real-Time Price · USD
0.9544
-0.1756 (-15.54%)
May 14, 2025, 2:33 PM - Market open

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021
Period Ending
 Dec '23 Dec '22 Dec '21
Allogeneic T Cell Therapies
95.00K
Log In
Log In
Allogeneic T Cell Therapies Growth
-60.91%
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021
Period Ending
 Dec '23 Dec '22 Dec '21
United States
95.00K
Log In
Log In
United States Growth
-60.91%
Log In
Log In